Navigation Links
Forecast Looks Good for India Pharma Shows

MAARSSEN, Netherlands, Nov. 9 /PRNewswire/ -- Momentum is building for the early December staging in Mumbai of the third CPhI India and second P-MEC India pharma ingredients, services and technologies event. A combined total of over 600 exhibitors from over 80 countries are expected at the Bombay Exhibition Centre for the 2009 events, being held on 1 - 3 December.

In addition to high quality exhibitors, the 2009 events include two new launches. BioPh India will focus on the convergence of technologies and business models in pharma and healthcare biotechnology - especially across the common interest areas of innovation, product development, clinical trials, manufacturing and supply logistics.

2009 also brings the debut of ICSE India, with emphasis on the very fast-growing outsourcing and contract services sector. The co-located additions of BioPh India and ICSE India to CPhI India and P-MEC India add impressive further depth and networking value to the combined events. The 2009 events will also be complemented by two major conferences.

CPhI India became the fourth member of the brand's global event "family" in 2006 and was joined by P-MEC India in 2007. The combined exhibitions are the largest pharma services event in India and South Asia. Despite the recent global slowdown, Indian pharma has maintained standout growth rates, with a sector forecast to quadruple, from US $6.3bn. in 2005 to US $25bn. in 2015.

In their mid-2009 report, and underlining the important addition of ICSE India - E&Y/OPPI (Ernst & Young/Organisation of Pharmaceutical Producers of India - OPPI) noted that India's outsourcing sector is growing at 43%, with drug discovery and development segment growing at 65% - well over three times the global average. India is targeting to become one of the top five innovator countries by 2020.

Growth will figure strongly in the major conferences complementing the exhibitions. These begin with the Indian Pharma Summit on Monday 30 November, focusing on: "The future of India Pharma - India Pharma Vision 2020" addressing the issues, opportunities and challenges for India as an emerging global pharma hub.

The event will be chaired by Ashok Kumar, Secty. Dept. of Pharmaceuticals and co-chaired by Glenn Saldhana, Chairman, FICCI National Pharmaceuticals Committee & MD and CEO, Glenmark Pharmaceuticals. Organisers are the Government of India's new Department of Pharmaceuticals and UBM India Pvt. Ltd. Venue is the Mumbai Grand Hyatt.

Staged alongside the first two days of CPhI India, in the BioPh pavilion at the Bombay Exhibition Centre, Biosimilars India 2009 will cover a wide range of topics in 17 sessions across three half-day modules.

"India is now moving towards centrestage in world pharma, with its overall pharma market growing at better than 9% - and key segments much faster. CPhI and the co-located events are the natural meeting point that enables a high level of networking and business development across the academic, development, R&D, services and manufacturing communities", said CPhI India Event Director Annemieke Timmers.

"With the BioPh India and ICSE India launches and a strong conference programme adding to a high level of pre-registrations, all our indications are that this year in Mumbai will see our strongest Indian events so far", added ICSE, BioPh and P-MEC Event Director Haf Cennydd.

Key industry organisations supporting the exhibitions will include Pharmexcil - the Government of India's pharmaceutical export promotion council; the Indian Drug Manufacturers Association (IDMA); the Organisation of Pharmaceutical Producers of India (OPPI) and the Bulk Drug Manufacturers Association (India) (BDMA).

The events are jointly organised by UBM International Media and sister company UBM India Pvt. Ltd.

UBM International Media's annual sister events for the pharma ingredients and services sector include Worldwide (Europe - October); Japan (April); China (June); and South America (August). For websites, see:;; and .

Notes for Editors:

  • UBM International Media operates market-leading global exhibition brands and their complementary media products.
  • The CPhI pharmaceutical ingredients and related sector exhibitions currently number over 12 highly-regarded annual events. The portfolio also includes Informex (speciality chemicals), Food Ingredients, HBA (health & beauty industry) and Sea Trade (cruise industry).
  • Worldwide locations for its events include China, India, Japan, North America, Brazil, Africa and Europe. More than 330,000 business professionals and marketers visit UBM exhibitions each year. The exhibitions portfolio is managed from Holland. UBM International Media has approximately 1,200 employees in the UK, US, Asia and Europe. See


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
3. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
4. Reportlinker Adds Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015
5. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
6. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
7. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
8. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
9. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
10. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
11. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
Post Your Comments:
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):